Development
2019
Over 20 automated modules were researched and the system had accomplished module automation and automatic testing platform.
2020
XImanging has accomplished the integrated module process automation for intelligent whole process nucleic acid testing of Songjiang Disease Control Center in Shanghai.
2021
(To energize life science )XImaging devotes to whole process automatic super laboratory and energize life science, pharmaceutical research and synthesis biology areas. The breakthrough of protein purification and cell line screening has been achieved.
2022
(Shanghai demonstration laboratory) The laboratory in Shanghai Temperature Technology Park was built to forge ISO7 biological demonstration laboratory.
(AI pharmaceutical research) The intelligent robot laboratory of AI pharmaceutical research was accomplished and put into use in China.
(Biological pharmaceutical) A mRNA automated research laboratory was finished and put into use which will contribute to billions mRNA vaccines research and production.
融资历史
2018年，天使轮融资：由紫竹小苗基金朗程资本战略投资；
2021年，完成Pre-A轮融资：由梧桐树资本、零一创投共同投资；
2022年，完成A轮亿级人民币融资：由字节跳动领投，由联想之星、零一创投等公司跟投；
资质荣誉
2018年 高新技术企业
2021年 上海市专精特新企业、闵行区专精特新企业
2022年 闵行区重点企业
2022年 上海闵行区创新型中小企
商业合作
2019年，推出新品智能EDX重金属测试系统，并与岛津（中国）签订合作项目成为EDX自动化唯一指定合作商
2021年，与知名AI新药研发公司英矽智能(Insilico Medicine)建立战略合作关系
Glories and Certifications
ISO9001 Quality Management System
SEMs
National High Technology Expertise
ISO9001 Quality Management System
